- Home
- AYTU vs WATT Comparison
AYTU vs WATT Comparison
Compare AYTU & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- WATT
- Stock Information
- Founded
- AYTU N/A
- WATT 2012
- Country
- AYTU United States
- WATT United States
- Employees
- AYTU N/A
- WATT N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- AYTU Health Care
- WATT Technology
- Exchange
- AYTU Nasdaq
- WATT Nasdaq
- Market Cap
- AYTU 8.3M
- WATT 9.1M
- IPO Year
- AYTU N/A
- WATT 2014
- Fundamental
- Price
- AYTU $1.15
- WATT $0.31
- Analyst Decision
- AYTU
- WATT Strong Buy
- Analyst Count
- AYTU 0
- WATT 2
- Target Price
- AYTU N/A
- WATT $2.25
- AVG Volume (30 Days)
- AYTU 37.1K
- WATT 603.9K
- Earning Date
- AYTU 05-14-2025
- WATT 05-13-2025
- Dividend Yield
- AYTU N/A
- WATT N/A
- EPS Growth
- AYTU N/A
- WATT N/A
- EPS
- AYTU N/A
- WATT N/A
- Revenue
- AYTU $77,232,000.00
- WATT $768,000.00
- Revenue This Year
- AYTU N/A
- WATT $1,028.91
- Revenue Next Year
- AYTU $8.14
- WATT N/A
- P/E Ratio
- AYTU N/A
- WATT N/A
- Revenue Growth
- AYTU N/A
- WATT 62.02
- 52 Week Low
- AYTU $1.15
- WATT $0.26
- 52 Week High
- AYTU $3.45
- WATT $2.70
- Technical
- Relative Strength Index (RSI)
- AYTU 33.76
- WATT 45.03
- Support Level
- AYTU $1.20
- WATT $0.26
- Resistance Level
- AYTU $1.29
- WATT $0.31
- Average True Range (ATR)
- AYTU 0.06
- WATT 0.03
- MACD
- AYTU 0.00
- WATT 0.00
- Stochastic Oscillator
- AYTU 0.00
- WATT 44.55
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.